NASDAQ:BCAB BioAtla (BCAB) Insider Trading & Ownership $1.72 -0.07 (-3.91%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$1.67▼$1.8250-Day Range$1.79▼$3.0752-Week Range$1.67▼$11.73Volume294,936 shsAverage Volume522,017 shsMarket Capitalization$82.22 millionP/E RatioN/ADividend YieldN/APrice Target$15.33 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media BioAtla (NASDAQ:BCAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.38%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$201,217.00Number OfInsiders Selling(Last 12 Months)0 Get BCAB Insider Trade Alerts Want to know when executives and insiders are buying or selling BioAtla stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCAB Insider Buying and Selling by Quarter BioAtla Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails9/8/2023Sylvia McbrinnDirectorBuy2,000$2.54$5,080.0011,125 3/29/2023Jay M Phd ShortCEOBuy40,800$2.47$100,776.001,412,387 3/28/2023Christian VasquezInsiderBuy20,000$2.40$48,000.00102,709 12/19/2022Sylvia McbrinnDirectorBuy3,700$8.33$30,821.009,125 11/22/2022Sylvia McbrinnDirectorBuy2,000$8.27$16,540.005,425 (Data available from 1/1/2013 forward) BCAB Insider Trading Activity - Frequently Asked Questions Who is on BioAtla's Insider Roster? The list of insiders at BioAtla includes Christian Vasquez, Cormorant Asset Management, Lp, Eric Sievers, Guy Levy, Jay M Phd Short, Lawrence Steinman, Richard A Waldron, Scott Andrew Smith, and Sylvia Mcbrinn. Learn more on insiders at BCAB. What percentage of BioAtla stock is owned by insiders? 8.38% of BioAtla stock is owned by insiders. Learn more on BCAB's insider holdings. Which BioAtla insiders have been buying company stock? The following insiders have purchased BCAB shares in the last 24 months: Christian Vasquez ($120,722.08), Jay M Phd Short ($388,498.78), and Sylvia Mcbrinn ($70,141.00). How much insider buying is happening at BioAtla? Insiders have purchased a total of 150,084 BCAB shares in the last 24 months for a total of $579,361.86 bought. Which BioAtla insiders have been selling company stock? The following insiders have sold BCAB shares in the last 24 months: Christian Vasquez ($75,408.25), Eric Sievers ($17,990.88), Jay M Phd Short ($1,763,347.17), Lawrence Steinman ($13,500.00), Richard A Waldron ($469,768.66), and Scott Andrew Smith ($137,222.19). How much insider selling is happening at BioAtla? Insiders have sold a total of 100,914 BioAtla shares in the last 24 months for a total of $2,477,237.15 sold. More Insider Trading Tools from MarketBeat Related Companies: OCGN Insider Trades CCCC Insider Trades KOD Insider Trades TALS Insider Trades VXRT Insider Trades LIFE Insider Trades NSTG Insider Trades GMDA Insider Trades TSBX Insider Trades TCRX Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders and Institutions are Scooping Up SelectQuoteInstitutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying This page (NASDAQ:BCAB) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.